Encompass HealthEHC.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Fair Value Range” zone.
As of Oct 16, 2026, Encompass Health (EHC.N) trades at a P/E of 20.30x, P/B of 4.76x, P/S of 2.03x, and a dividend yield of 0.60%.
Longitudinal percentile comparison: P/E sits at the 46th percentile over the trailing 10Y window (vs. 40th percentile over 3Y); P/B sits at the 47th percentile over the trailing 10Y window (vs. 46th percentile over 3Y); P/S sits at the 95th percentile over the trailing 10Y window (vs. 85th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 44th percentile within its industry and the 53rd percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 1.85%, ranking at the 61st percentile over the trailing 20Y window.
The P/E and P/B long-window percentiles differ by only 1.1 points, pointing to a consistent valuation read across both metrics. Relative to industry peers, its P/E shows a deeper discount than it does against the broader market. Breaking down the total shareholder yield: 0.60% comes from cash dividends, with an implied ~1.25% from buybacks — a fairly balanced mix of both channels. Encompass Health operates in the Services sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: EHC · EHC
Want the full picture on whether Encompass Health (EHC.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | 20.30 | ||||||
| P/B (MRQ) | 4.76 | ||||||
| P/S (TTM) | 2.03 | ||||||
| Dividend Yield | 0.60% | ||||||
| Buyback + Div Yield | 1.85% |